News & Analysis as of August 29, 2025

Corporate Governance

+ Follow

Read guidance, analysis, and updates on the myriad issues arising from the global response to the COVID-19 pandemic. Updated hourly every day, the insights published here are written by leading lawyers and law firms helping to make sense of insurance, employment, tax, securities, M&A, risk management, and every other consideration touched by this crisis. Follow the channel for a daily email brief of the latest and best updates. less -

Regulatory Escalation in Pharma Sector: China Imposes First Executive Sanctions in a Cartel Case

Dacheng on 5/27/2025

On May 9, 2025, the Tianjin Municipal Administration for Market Regulation (“Tianjin AMR”) announced administrative penalties against four manufacturers of dexamethasone sodium phosphate (“DSP”) active pharmaceutical...more

Key Considerations for the 2022 Annual Reporting and Proxy Season

White & Case LLP on 2/21/2022

This memorandum outlines key considerations for U.S. public companies in preparation for the 2022 annual reporting and proxy season. ▪️ Part I of this memo, which was published in January 2022, describes key...more

Is A Safer Healthcare System Within Reach?

Akerman LLP - Health Law Rx on 11/4/2020

COVID-19 has made healthcare organizations acutely aware of the need to fine-tune their internal safety systems. The National Steering Committee for Patient Safety (NSC), comprised of 27 organizations, has come to the rescue....more

3 Results

View per page

Page: of 1

Coronavirus/COVID-19 › Regulatory Oversight › Corporate Governance

Regulatory Escalation in Pharma Sector: China Imposes First Executive Sanctions in a Cartel Case

Key Considerations for the 2022 Annual Reporting and Proxy Season

Is A Safer Healthcare System Within Reach?

"My best business intelligence, in one easy email…"